Thrombocytosis on Adult Patient with SARS-Cov-2 in Africa

Authors: Ngolet LO*, Kie FU, Moyikoua R and Ngokaba TO

DOI: 10.23880/hij-16000166

Volume 4, Issue 2

Abstract

The 2019-2020 pandemic caused by a novel coronavirus, SARS-Cov-2 or COVID-19 is ongoing. The outbreak of a respiratory illness caused by COVID-19 was first identified in Wuhan, Hubei Province, China and declared by the local authorities in December 2019. Since the beginning of the pandemic, Governments and health authorities across the world are striving to limit the widespread of the virus. The African continent registered its first cases about two months ago, and then readily implemented massive preventive measures such as lockdown, confinement and curfew. Like others, African Scientists are learning from and sharing their experiences about the disease. The aim of this article is to present a case of a COVID-19-related moderate pneumonia with unusual laboratory findings. This study has been approved by the local bioethics committee.

Keywords: Novel Coronavirus; SARS-Cov-2 pneumonia

View PDF